GO:0035333 Notch receptor processing, ligand-dependent: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035333 describes the ligand-triggered proteolytic cleavages of the Notch receptor that release the Notch intracellular domain (NICD).
• Ligand binding exposes a hidden extracellular cleavage site (S2), which is cleaved by ADAM metalloproteases to produce a membrane-tethered NICD fragment.
• A subsequent intramembrane cleavage (S3) by the gamma-secretase complex liberates soluble NICD, which translocates to the nucleus to regulate transcription.
• Ligand endocytosis in the signal-sending cell is a key step that generates the mechanical force needed to expose the S2 site.
• Dysregulated Notch processing is implicated in cancers and other diseases, making it a target for therapeutic intervention.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of each processing step [2,5].
Description
Notch signaling is an evolutionarily conserved cell-cell communication pathway that controls cell fate decisions, proliferation, and differentiation. The core event in this pathway is the ligand-dependent proteolytic processing of the Notch receptor, formally annotated as GO:0035333 (Notch receptor processing, ligand-dependent). This process converts a single-pass transmembrane receptor into a soluble intracellular effector, the Notch intracellular domain (NICD), which directly regulates gene expression. Understanding GO:0035333 is therefore essential for researchers studying development, tissue homeostasis, and diseases such as cancer. The term encompasses two sequential cleavages: an extracellular S2 cleavage that requires ligand binding and a transmembrane S3 cleavage that releases NICD. These steps are tightly regulated by endocytic trafficking, glycosylation, and the mechanical forces generated by ligand endocytosis [3,6,7].
Notch receptor processing, ligand-dependent At A Glance
| GO ID | GO:0035333 |
|---|---|
| GO term | Notch receptor processing, ligand-dependent |
| Ontology | biological_process |
| Synonym | Notch S2 cleavage, Notch S3 cleavage |
| Major function | Ligand-triggered proteolysis of Notch to release NICD for transcriptional regulation |
| Key enzymes | ADAM metalloproteases (S2), gamma-secretase complex (S3) |
| Cellular location | Plasma membrane and endosomal compartments |
| Regulatory input | Ligand endocytosis, O-glycosylation, trafficking [6,7] |
What Is GO:0035333?
GO:0035333 (Notch receptor processing, ligand-dependent) is the set of proteolytic cleavages that occur on the Notch protein specifically after a ligand binds to it. Ligand binding at the cell surface exposes a previously inaccessible cleavage site in the extracellular portion of Notch; cleavage there releases a membrane-tethered form of the Notch intracellular domain. A subsequent cleavage within the transmembrane domain then releases the soluble Notch intracellular domain (NICD).
Why Is Notch receptor processing, ligand-dependent Important in Cell Biology?
GO:0035333 is the central activation step of Notch signaling, a pathway that governs cell fate, stem cell maintenance, and tissue patterning. Because the pathway is frequently dysregulated in human cancers and other diseases, understanding the precise molecular events of ligand-dependent processing is critical for developing targeted therapies. Moreover, the mechanical and trafficking requirements for this process make it a paradigm for studying how cells convert extracellular cues into transcriptional outputs.
• Controls cell fate decisions during development and adult tissue homeostasis.
• Dysregulated in multiple cancers, including T-cell acute lymphoblastic leukemia and breast cancer.
• Requires ligand endocytosis in the signal-sending cell, linking mechanical force to signaling.
• O-glycosylation of Notch modulates ligand-dependent processing and is altered in cancer.
• Provides a model for understanding intramembrane proteolysis and regulated receptor shedding.
• Targeted by gamma-secretase inhibitors, which are in clinical trials for Notch-driven cancers.
• Endocytic trafficking of Notch is essential for proper processing and signaling.
• Ligand-independent Notch signaling can occur in T-cells, highlighting context-specific regulation.
What Happens During Notch receptor processing, ligand-dependent?
Ligand binding and S2 cleavage
In simple terms: When a ligand on a neighboring cell binds to Notch, it pulls the receptor and exposes a hidden cut site.
Ligand binding at the cell surface exposes an otherwise inaccessible cleavage site in the extracellular portion of Notch. This site, known as S2, is cleaved by ADAM metalloproteases, releasing a membrane-tethered form of the Notch intracellular domain. Ligand endocytosis in the signal-sending cell generates the necessary mechanical force to expose the S2 site.
S3 cleavage and NICD release
In simple terms: After the first cut, a second cut inside the membrane releases the Notch tail so it can travel to the nucleus.
Following S2 cleavage, the membrane-tethered Notch fragment undergoes intramembrane cleavage at the S3 site by the gamma-secretase complex. This cleavage liberates the soluble Notch intracellular domain (NICD), which translocates to the nucleus to regulate transcription.
Role of endocytic trafficking
In simple terms: Notch and its ligands are moved around inside the cell, and this movement is required for the cuts to happen.
Endocytic trafficking of the Notch receptor is essential for its ligand-dependent processing. Ligand endocytosis in the signal-sending cell is required for Notch activation, and defects in trafficking can impair signaling. The endosomal pathway also contributes to the regulation of Notch processing and degradation.
Modulation by O-glycosylation
In simple terms: Sugar molecules added to Notch can change how well it is cut and how strongly it signals.
O-glycosylation of the Notch extracellular domain modulates ligand-dependent processing and signaling. Alterations in O-glycosylation are observed in cancer and can affect Notch activity.
Key Genes Involved in GO:0035333 Notch receptor processing, ligand-dependent
The following genes and proteins are central to the ligand-dependent processing of Notch (GO:0035333).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Notch receptor; substrate for S2 and S3 cleavages | Mutations and dysregulation in T-ALL and other cancers |
| NOTCH2 | Notch receptor paralog | Implicated in breast cancer and developmental disorders |
| NOTCH3 | Notch receptor paralog | Associated with CADASIL and some cancers |
| NOTCH4 | Notch receptor paralog | Role in breast cancer and angiogenesis |
| DLL1 | Notch ligand (Delta-like) | Ligand endocytosis required for Notch activation |
| DLL3 | Notch ligand (Delta-like) | Target in small cell lung cancer |
| DLL4 | Notch ligand (Delta-like) | Regulates angiogenesis; target in cancer |
| JAG1 | Notch ligand (Jagged) | Mutations in Alagille syndrome |
| JAG2 | Notch ligand (Jagged) | Role in cancer and development |
| ADAM10 | Metalloprotease for S2 cleavage | Required for ligand-dependent Notch processing |
| ADAM17 | Metalloprotease for S2 cleavage | Contributes to Notch processing in some contexts |
| PSEN1 | Catalytic subunit of gamma-secretase for S3 cleavage | Mutations in Alzheimer's disease; target for inhibitors |
| PSEN2 | Gamma-secretase subunit | Similar to PSEN1 |
| NCSTN | Gamma-secretase subunit | Component of the S3 cleavage complex |
| APH1 | Gamma-secretase subunit | Component of the S3 cleavage complex |
| PEN2 | Gamma-secretase subunit | Component of the S3 cleavage complex |
| MAML1 | Transcriptional coactivator for NICD | Required for Notch target gene activation |
| RBPJ | DNA-binding transcription factor for NICD | Mediates Notch target gene expression |
How Is Notch receptor processing, ligand-dependent Regulated?
Ligand-dependent Notch processing is regulated at multiple levels. Ligand endocytosis in the signal-sending cell is required to generate the force needed for S2 cleavage. O-glycosylation of the Notch extracellular domain by enzymes such as Fringe modulates ligand binding and processing efficiency. Endocytic trafficking of Notch itself controls the availability of the receptor for cleavage and can direct it to degradation or recycling. Additionally, the gamma-secretase complex activity can be influenced by its subunit composition and post-translational modifications.
Notch receptor processing, ligand-dependent and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | T-cell acute lymphoblastic leukemia | Knockout or point-mutation in T-ALL cell lines |
| JAG1 | Alagille syndrome | Knock-in of patient mutations in iPSCs |
| PSEN1 | Alzheimer's disease | Knock-in of familial mutations in neuronal cells |
| ADAM10 | Cancer and inflammatory diseases | Knockout in cancer cell lines to block S2 cleavage |
| DLL4 | Angiogenesis and cancer | Overexpression or knockout in endothelial cells |
Notch processing in cancer
Dysregulated Notch signaling, often through mutations in NOTCH1 or altered expression of ligands and processing enzymes, contributes to multiple cancers including T-cell acute lymphoblastic leukemia, breast cancer, and others. Targeting Notch trafficking and processing has emerged as a therapeutic strategy.
Notch and developmental disorders
Mutations in JAG1 or NOTCH2 cause Alagille syndrome, a developmental disorder affecting liver, heart, and other organs. Defects in Notch processing can disrupt normal development.
Notch in neurological disease
The gamma-secretase complex, which performs S3 cleavage, is also involved in processing amyloid precursor protein; mutations in PSEN1 and PSEN2 are linked to early-onset Alzheimer's disease. However, the direct role of Notch processing in neurodegeneration is complex and context-dependent.
From Notch receptor processing, ligand-dependent-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate S2 cleavage? | Knockout of ADAM10 or ADAM17 in Notch-expressing cells |
| How do point mutations in NOTCH1 affect processing? | Point-mutation knock-in of patient-derived mutations |
| Can we track NICD release in real time? | Tagged knock-in of NOTCH1 with fluorescent protein |
| What is the role of O-glycosylation in processing? | Overexpression or knockout of glycosyltransferases |
| Does ligand endocytosis drive Notch activation? | Knockout of dynamin or clathrin in ligand-expressing cells |
| Can we screen for modulators of Notch processing? | CRISPR library screening in reporter cell lines |
How to Study the Notch receptor processing, ligand-dependent Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in gene expression | Assess Notch target gene activation after processing |
| Western blot | Protein cleavage products (NICD, NEXT) | Validate S2/S3 cleavage in mutant cells |
| Immunofluorescence | Subcellular localization of Notch and ligands | Track endocytosis and trafficking |
| Co-immunoprecipitation | Protein-protein interactions | Identify components of the processing complex |
| Mass spectrometry | Post-translational modifications | Map O-glycosylation sites on Notch |
| CRISPR screen | Genes affecting Notch signaling | Discover novel regulators of processing |
| Luciferase reporter | Notch transcriptional activity | Measure NICD production indirectly |
| Flow cytometry | Cell surface Notch levels | Quantify receptor internalization and cleavage |
RNA sequencing and transcriptomics
RNA-seq can measure changes in Notch target gene expression following manipulation of processing components. It provides a global view of transcriptional consequences of altered GO:0035333 activity.
Proteomics and western blotting
Western blotting with antibodies against Notch extracellular and intracellular domains can detect the cleavage products (NEXT, NICD) and assess processing efficiency. Mass spectrometry can identify interacting proteins and post-translational modifications.
Imaging and live-cell assays
Fluorescence microscopy of tagged Notch and ligands can visualize endocytosis, trafficking, and cleavage events in real time [3,6]. FRET-based sensors can detect NICD release.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate Notch processing and signaling. These screens are powerful for discovering novel regulators of GO:0035333.
How CRISPR Can Be Used to Study GO:0035333 Notch receptor processing, ligand-dependent
Knockout
CRISPR knockout of genes such as ADAM10, PSEN1, or NOTCH1 itself can abolish specific cleavage steps, allowing researchers to dissect their roles in GO:0035333 [2,5]. Knockout cell lines are valuable for confirming the requirement of a gene in ligand-dependent processing.
Point Mutation
Introducing point mutations that mimic patient-derived variants (e.g., in NOTCH1 or PSEN1) via CRISPR can reveal how specific amino acid changes affect S2 or S3 cleavage. This approach helps link genotype to processing defects.
Knock-in
Knock-in of tagged Notch (e.g., GFP or luciferase) enables real-time tracking of receptor processing and NICD release. Knock-in of reporter genes under Notch target promoters provides a readout of pathway activity.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of Notch ligands or processing enzymes can enhance pathway activity, useful for studying gain-of-function effects [5,6]. Overexpression models help identify rate-limiting steps in processing.
How EDITGENE Supports Notch receptor processing, ligand-dependent Research
Researchers studying Notch receptor processing, ligand-dependent-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activity. CRISPR-based models provide a direct way to test causality by precisely manipulating the genome.
Contact EDITGENE today to design your custom CRISPR model for Notch receptor processing, ligand-dependent research.
Frequently Asked Questions About Notch receptor processing, ligand-dependent
What is GO:0035333?
GO:0035333 is the Gene Ontology term for Notch receptor processing, ligand-dependent, which describes the proteolytic cleavages of Notch that occur after ligand binding and lead to release of the Notch intracellular domain (NICD).
What genes are involved in Notch receptor processing, ligand-dependent?
Key genes include NOTCH1-4, ligands DLL1/3/4 and JAG1/2, metalloproteases ADAM10/17, and gamma-secretase subunits PSEN1/2, NCSTN, APH1, and PEN2 [2,5].
What are the synonyms for GO:0035333?
The synonyms are Notch S2 cleavage and Notch S3 cleavage.
Why is ligand-dependent Notch processing important?
It is the central activation step of Notch signaling, controlling cell fate and implicated in cancers and developmental disorders [2,5].
What is the role of ADAM10 in Notch processing?
ADAM10 is a metalloprotease that performs the S2 cleavage of Notch after ligand binding, releasing a membrane-tethered NICD fragment.
How does gamma-secretase contribute to Notch processing?
Gamma-secretase performs the S3 cleavage within the transmembrane domain, releasing soluble NICD.
What diseases are linked to defects in Notch processing?
Cancers such as T-ALL and breast cancer, as well as Alagille syndrome and Alzheimer's disease, have been linked to Notch pathway components.
How can CRISPR be used to study Notch processing?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes to test their roles in processing [2,5].
What experimental methods are used to study GO:0035333?
Common methods include western blotting, immunofluorescence, RNA-seq, proteomics, and CRISPR screens [1,2,3,5].
What is the difference between S2 and S3 cleavage?
S2 cleavage occurs in the extracellular domain after ligand binding, while S3 cleavage occurs within the transmembrane domain and releases NICD.
Conclusion
GO:0035333 (Notch receptor processing, ligand-dependent) is a fundamental biological process that converts extracellular ligand binding into a transcriptional response through sequential proteolytic cleavages. Its tight regulation by endocytosis, glycosylation, and trafficking ensures precise signaling during development and tissue homeostasis [3,6,7]. Dysregulation of this process contributes to various diseases, making it a key area of research. CRISPR-based models and advanced screening methods continue to uncover new details about this pathway, offering potential therapeutic targets.
References
- 1. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 2. Steinbuck MP et al.. 2018. A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells.. Front Immunol 9:1230 PMID: 29910816
- 3. Schnute B et al.. 2018. Endocytic Trafficking of the Notch Receptor.. Adv Exp Med Biol 1066:99-122 PMID: 30030824
- 5. Pagliaro L et al.. 2020. Targeting Notch Trafficking and Processing in Cancers.. Cells 9(10) PMID: 33003595
- 6. Seib E et al.. 2021. The role of ligand endocytosis in notch signalling.. Biol Cell 113(10):401-418 PMID: 34038572
- 7. Wang W et al.. 2022. Significant Roles of Notch O-Glycosylation in Cancer.. Molecules 27(6) PMID: 35335147
